These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19914539)

  • 61. Predictive molecular pathology.
    Sauter G; Simon R
    N Engl J Med; 2002 Dec; 347(25):1995-6. PubMed ID: 12490679
    [No Abstract]   [Full Text] [Related]  

  • 62. 26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on preclinical and translational research.
    Lee AV; Chamness G; Oesterreich S
    Breast Cancer Res; 2004 Jan; 6(2):E10. PubMed ID: 14979916
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A new prognostic tool on the horizon for breast cancer?
    Bradbury J
    Lancet; 2001 Sep; 358(9286):989. PubMed ID: 11583758
    [No Abstract]   [Full Text] [Related]  

  • 64. Breast cancer prognostic markers: where are we now?
    Gökmen-Polar Y; Badve S
    MLO Med Lab Obs; 2012 Sep; 44(9):22, 24-5. PubMed ID: 23002506
    [No Abstract]   [Full Text] [Related]  

  • 65. Genomic analyses to select patients for adjuvant chemotherapy: trials and tribulations.
    Weigelt B; Reis-Filho JS; Swanton C
    Ann Oncol; 2012 Sep; 23 Suppl 10():x211-8. PubMed ID: 22987965
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gene expression profiling of breast cancer.
    Pusztai L
    Breast Cancer Res; 2009; 11 Suppl 3(Suppl 3):S11. PubMed ID: 20030862
    [No Abstract]   [Full Text] [Related]  

  • 67. Gene-expression signatures in breast cancer.
    Sotiriou C; Pusztai L
    N Engl J Med; 2009 Feb; 360(8):790-800. PubMed ID: 19228622
    [No Abstract]   [Full Text] [Related]  

  • 68. Huge emphasis placed on gene-expression profiling test by breast cancer patients.
    Jones S
    Pharmacogenomics; 2014 May; 15(7):903. PubMed ID: 25090663
    [No Abstract]   [Full Text] [Related]  

  • 69. [Genome-wide expression profiling as a clinical tool: are we there yet?].
    Geyer FC; Decker T; Reis-Filho JS
    Pathologe; 2009 Mar; 30(2):141-6. PubMed ID: 19219435
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genome-based risk prediction for early stage breast cancer.
    Adaniel C; Jhaveri K; Heguy A; Esteva FJ
    Oncologist; 2014 Oct; 19(10):1019-27. PubMed ID: 25187476
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry.
    Weigelt B; Reis-Filho JS
    Breast Cancer Res; 2010 Dec; 12 Suppl 4(Suppl 4):S5. PubMed ID: 21172089
    [No Abstract]   [Full Text] [Related]  

  • 72. Microarrays in primary breast cancer--lessons from chemotherapy studies.
    Lønning PE; Sørlie T; Perou CM; Brown PO; Botstein D; Børresen-Dale AL
    Endocr Relat Cancer; 2001 Sep; 8(3):259-63. PubMed ID: 11566617
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust.
    Piccart MJ; Kalinsky K; Gray R; Barlow WE; Poncet C; Cardoso F; Winer E; Sparano J
    Ann Oncol; 2021 Sep; 32(9):1077-1082. PubMed ID: 34082017
    [No Abstract]   [Full Text] [Related]  

  • 74. From gene testing to the bedside: workshop focuses on future strategies.
    Goozner M
    J Natl Cancer Inst; 2011 Aug; 103(15):1150-1. PubMed ID: 21768535
    [No Abstract]   [Full Text] [Related]  

  • 75. Using molecular profiling diagnostics to identify predictive biomarkers in metastatic cancer.
    Van Tine BA
    MLO Med Lab Obs; 2014 Sep; 46(9):18, 20-1. PubMed ID: 25252395
    [No Abstract]   [Full Text] [Related]  

  • 76. Molecular profiling contributes more than routine histology and immonohistochemistry to breast cancer diagnostics.
    Shiang C; Pusztai L
    Breast Cancer Res; 2010 Dec; 12 Suppl 4(Suppl 4):S6. PubMed ID: 21172090
    [No Abstract]   [Full Text] [Related]  

  • 77. Challenges translating breast cancer gene signatures into the clinic.
    Weigelt B; Pusztai L; Ashworth A; Reis-Filho JS
    Nat Rev Clin Oncol; 2011 Aug; 9(1):58-64. PubMed ID: 21878891
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment tailoring based on molecular characterizations.
    Dinh P; Sotiriou C
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii46-50. PubMed ID: 18790978
    [No Abstract]   [Full Text] [Related]  

  • 79. Patient profiling in breast cancer--is knowledge power?
    Kirk R; Villanueva MT; Hutchinson L
    Nat Rev Clin Oncol; 2011 Dec; 9(1):1. PubMed ID: 22186933
    [No Abstract]   [Full Text] [Related]  

  • 80. The MINDACT trial: the first prospective clinical validation of a genomic tool.
    Cardoso F; Piccart-Gebhart M; Van't Veer L; Rutgers E;
    Mol Oncol; 2007 Dec; 1(3):246-51. PubMed ID: 19383299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.